Publications by authors named "Inga-Maria Launonen"

Claim this Profile
M
Multi-omics analysis reveals the attenuation of the interferon pathway as a driver of chemo-refractory ovarian cancer.
Daria Afenteva, Rong Yu, Anna Rajavuori, Marina Salvadores, Inga-Maria Launonen

Cell Rep Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tribus: semi-automated discovery of cell identities and phenotypes from multiplexed imaging and proteomic data.
Ziqi Kang, Angela Szabo, Teodora Farago, Fernando Perez-Villatoro, Ada Junquera, Inga-Maria Launonen

Bioinformatics· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer.
Inga-Maria Launonen, Iga Niemiec, María Hincapié-Otero, Erdogan Pekcan Erkan, Ada Junquera

Cancer Cell· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer.
Inga-Maria Launonen, Erdogan Pekcan Erkan, Iga Niemiec, Ada Junquera, María Hincapié-Otero

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Emerging Role of the Single-Cell and Spatial Tumor Microenvironment in High-Grade Serous Ovarian Cancer.
Inga-Maria Launonen, Anna Vähärautio, Anniina Färkkilä

Cold Spring Harb Perspect Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer.
Liya Ding, Qiwei Wang, Antons Martincuks, Michael J Kearns, Tao Jiang, Inga-Maria Launonen

J Immunother Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples.
Sadia Zafar, Saru Basnet, Inga-Maria Launonen, Dafne Carolina Alves Quixabeira, Joao Santos

Hum Gene Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis